A significant finding from ENDO 2026 demonstrates that endocrine-disrupting chemicals are present in both breast milk and infant urine throughout the first six months of life. This dual detection across two biological matrices suggests multiple exposure pathways during a period of rapid development and heightened physiological vulnerability.
The research, presented at the Endocrine Society’s annual meeting, tracked infants from birth through six months, consistently identifying these hormone-interfering substances. The consistent presence across this critical developmental window raises concerns about the cumulative impact of early-life chemical exposure.
These preliminary findings emphasize the importance of understanding how endocrine-disrupting chemicals reach infants and the potential implications for long-term health outcomes during development.
Was this article helpful?
